Wed, Jul 23, 2014, 1:46 AM EDT - U.S. Markets open in 7 hrs 44 mins

Recent

% | $
Click the to save as a favorite.

Senomyx Inc. Message Board

you are viewing a single comment's thread.

view the rest of the posts
  • kal555man kal555man Jan 15, 2010 10:52 AM Flag

    Might be a run for te money

    Just the beginning with the Stevia potential, it's a natural
    product not artificial as you claim. The plant(s) have extraordinary commercial application as is and with some additional research.

    Stevia is a genus of about 240 species of herbs and shrubs in the sunflower family (Asteraceae), native to subtropical and tropical South America and Central America. The species Stevia rebaudiana, commonly known as sweetleaf, sweet leaf, sugarleaf, or simply stevia, is widely grown for its sweet leaves. As a sweetener and sugar substitute, stevia's taste has a slower onset and longer duration than that of sugar, although some of its extracts may have a bitter or licorice-like aftertaste at high concentrations.

    With its extracts having up to 300 times the sweetness of sugar, stevia has garnered attention with the rise in demand for low-carbohydrate, low-sugar food alternatives. Medical research has also shown possible benefits of stevia in treating obesity and high blood pressure. Because stevia has a negligible effect on blood glucose, it is attractive as a natural sweetener to people on carbohydrate-controlled diets. However, health and political controversies have limited stevia's availability in many countries; for example, the United States banned it in the early 1990s unless labeled as a supplement, although in 2008 it became commercially available as a sweetener. Stevia is widely used as a sweetener in Japan, and it is available in Canada as a dietary supplement.

 
SNMX
7.77-0.09(-1.15%)Jul 22 4:00 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.